In fact, when adjusted uniquely for WC, the difference in CERT1 between the OB-MetS− and NW groups disappeared, while that between the OB-MetS+ and NW groups was maintained; moreover, when combining WC with CRP or HOMA-IR as covariates, i.e., visceral adiposity with chronic low-grade inflammation or insulin-resistance, it was possible to abate the difference in CERT1 between the OB-MetS+ and NW groups. This evidence concerns the gene CERT1 and metabolic syndrome.